Valneva SE American Depositary Shares

VALN XNAS

Market Cap

490M

Short interest (Jul 15)

0.2%

Net Short (Jul 27 ): 0.0%

Borrow Fee

2.99%

Available Shares

200K

Price Chart

Company Overview

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Company Info

Exchange: NASDAQ
CIK: 0001836564
Asset Type: ADRC

Market Data

Market Cap: $488,131,888
Employees: 674
Status: Active

Short Interest

Current Borrow Fee 2.99%
Range: 2.99% - 3.44%
Available Shares 200K
Range: 70K - 150K

Recent Changes

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime